TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Biokjemi Norge AS
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
2,093
|
1,800
|
2,501 |
Financial expenses |
26
|
20
|
19 |
Earnings before taxes |
32
|
-167
|
105 |
Total assets |
1,169
|
1,203
|
1,171 |
Current assets |
912
|
913
|
845 |
Current liabilities |
700
|
736
|
501 |
Equity capital |
469
|
467
|
670 |
- share capital |
9
![]() |
9
|
10 |
Employees (average) |
6
![]() |
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
40.1%
|
38.8%
|
57.2% |
Turnover per employee |
300
|
417 | |
Profit as a percentage of turnover |
1.5%
|
-9.3%
|
4.2% |
Return on assets (ROA) |
5.0%
|
-12.2%
|
10.6% |
Current ratio |
130.3%
|
124.0%
|
168.7% |
Return on equity (ROE) |
6.8%
|
-35.8%
|
15.7% |
Change turnover |
407
|
-570
|
-442 |
Change turnover % |
24%
|
-24%
|
-15% |
Chg. No. of employees |
0
![]() |
0 | |
Chg. No. of employees % |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.